SELECT ISSUE

Romanian Journal of Neurology, Volume XIV, No. 2, 2015
ISSN 1843-8148  |  e-ISSN 2069-6094
ISSN-L 1843-8148

Indexată BDI  |  IDB Indexed

Ebsco Host - Medline
Scopus

HIGHLIGHTS

Plagiatul – în actualitate

Tema plagiatului este tot mai mult discutată în ultima vreme. Apariția unor programe performante de căutare și identificare a similitudinilor între texte [...]

Committe on Publication Ethics

A forum for responsible and ethical research publishing – Code of Conduct and Best Practice Guidelines for Journal Editors.

PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMAS

ABSTRACT

Primary central nervous system lymphoma (PCNSL) is an aggressive non-Hodgkin B-cell lymphoma with characteristic clinical behavior, biological features and poor prognosis despite complex treatment. PCNSL has a median survival of 17 to 45 months in immunocompetent patients, and only 20-30% of cases can be cured successfully. Clinical outcome has improved since the advances in combination chemotherapy protocols, addition of whole brain radiation therapy, encouraging responses of rituximab adminsitration in refractory PCNSL and autologous hematopoietic stem-cell transplantation as consolidative therapy. The author review the recent data on pathogenesis, diagnostic methods and treatment strategies of PCNSL in immunocompetent patients.

Keywords: primary central nervous system lymphoma, pathogenesis, magnetic resonance imaging, 18-fluorodeoxyglucose positron emission tomography

Full text | PDF